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Letter to the Editor: 
Endovascular Treatment for Acute Ischaemic Stroke: Experience in South Australia 
 
Dear Editor, 






 trials showed intra-
arterial treatment in acute ischaemic stroke caused by proximal intracranial arterial occlusion 
resulted in better functional outcomes at 90 days when compared with standard treatment.  





We conducted a retrospective analysis of 31 consecutive patients treated with endovascular 
therapy for acute ischaemic stroke between November 2008 and December 2012 at The 
Queen Elizabeth Hospital, a tertiary referral centre at a time of change in South Australia.
7
 
Baseline characteristics and type of endovascular method are outlined in Table 1.  Outcomes 
were assessed using Arterial Occlusive Lesion (AOL) recanalisation scores and 90-day 
Modified Rankin Scores (mRS) (Table 2). 
 
Successful recanalisation, defined by AOL 2-3, was achieved in 77.4% of our patients.  This 




 comparable to ESCAPE
3
 and IMS III
6
 but 
higher than MR RESCUE.
4
 Our patient group had higher rates of death, intracranial 
haemorrhage (ICH) and worse functional outcomes than reported in EXTEND-IA, MR 
CLEAN, IMS III and SYNTHESIS.
1,2,5,6
 However our study showed better functional 
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We used multiple endovascular modalities, which limits comparison of our results; later-
generation mechanical devices may contribute to improved rates of recanalisation seen in the 
more recent trials.
2,8
 Furthermore our study included patients with posterior territory stroke, 
which were not included in MR CLEAN, EXTEND-IA, ESCAPE or MR RESCUE, although 
they were included in IMS III and SYNTHESIS.
1-6
 Stratification of our results showed these 
patients had poorer outcomes compared with anterior circulation vessel occlusion (Table 3).  
A number of factors may contribute to differences in outcomes including variability of 
interventional radiologist experience and time from stroke onset to treatment initiation.  In 
our patient group the mean time from stroke onset to arrival at hospital was 59 minutes.  This 
was better than the mean of 78 minutes in EXTEND-IA.
2
 Our mean time to initiation of 
intravenous thrombolysis was 123 minutes, which compares with 127 in EXTEND-IA, 122.4 
in IMS III, 110 in ESCAPE and 85 in MR CLEAN.
1-3,6
 Mean time to the commencement of 
endovascular therapy was 235 minutes in our study, 210 minutes in EXTEND-IA and 260 




Given the recently published evidence supporting endovascular therapy,
8
 we suggest it is 
important to report outcomes from past “real world experience” which in comparison to 
current evidence demonstrates why the initial studies were negative.  Translation of the 
current evidence to our stroke services is now the critical step for best clinical outcomes. 
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Age, years – mean (range) 66 (28-86) 
Male gender – n (%) 15 (48.4) 
Stroke 
Territory – n (%)  
Anterior 26 (83.9) 
Posterior 5 (16.1) 
Cause – n (%)  
Cardiogenic embolism 14 (45.2) 
Large-artery atherosclerosis 5 (16.1) 
Dissection 2 (6.5) 
Unknown 10 (32.3) 
NIHSS score, mean (range) 17 (7-28) 
Time from stroke onset – minutes, mean (range)  
To hospital (n=27)† 58.9 (20-194) 
To intravenous thrombolysis (n=14)‡ 123 (73-267) 
To endovascular therapy (n=31) 235 (45-405) 
Endovascular procedure 
Mechanical device or stent – n (%) 25 (80.6) 
Penumbra 20/25 (80) 
Solitaire 8/25 (32) 
Trevo 3/25 (12) 
Merci 1/25 (4) 
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Permanent stent 6/25 (24) 
Intra-arterial rtPA – n (%) 10 (32.3) 
*Data was recorded at time of presentation to hospital or at time of stroke if already an 
inpatient. 
†4 patients in hospital at the time of stroke were not included; 4 other patients were 
transferred from another hospital (time to arrival at initial hospital was used in these cases). 
‡16 patients underwent intravenous therapy prior to endovascular therapy; time parameters 
were recorded in 14. 
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Table 2. Complications and Outcomes (n=31) 
Complications – n (%) 
ICH  18 (58.1) 
Symptomatic 6 (19.4) 
Asymptomatic 12 (38.7) 
Symptomatic cerebral oedema  3 (9.7) 
Further stroke  2 (6.5) 
Bleeding at other sites  7 (22.6) 
Sepsis  9 (29) 
Death  9 (29) 
Outcome measures – n (%) 
AOL post-procedure   
0 5 (16.1) 
1 2 (6.5) 
2 9 (29) 
3 15 (48.4) 
mRS at 90 days*   
0-1 3 (10) 
0-2 8 (26.7) 
90-day mortality 14 (46.7) 
*Recorded in 30 patients. 
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Anterior 19/26 (73) 8/25 (32) 10/25 (40) 
Internal carotid artery  9/12 (75) 2/11(18) 5/11 (45) 
Middle cerebral artery, M1 7/10 (70) 4/10 (40) 4/10 (40) 
M2 – single occlusion 2/3 (66.7) 1/3 (33.3) 1/3 (33) 
M2 – multiple occlusions 1/1 (100) 1/1 (100) 0/1 (0) 
Posterior 5/5 (100) 0/5 (0) 4/5 (80) 
* Not recorded in 1 patient. 
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